(Q27489378)

9

0 references

Erna G. Kroon

object named as

Erna G Kroon

7

0 references

Mauro M Teixeira

13

object named as

Mauro M Teixeira

0 references

author name string

Danielle G Souza

1

0 references

Caio T Fagundes

2

0 references

Lirlandia P Sousa

3

0 references

Flavio A Amaral

4

0 references

Rafael S Souza

5

0 references

Adriano L Souza

6

0 references

Daniela Sachs

8

0 references

Eugenij Bukin

10

0 references

Alena Atrasheuskaya

11

0 references

George Ignatyev

Proceedings of the National Academy of Sciences of the United States of America

12

0 references

language of work or name

English

0 references

publication date

18 August 2009

0 references

published in

0 references

volume

106

0 references

issue

33

0 references

page(s)

14138-43

0 references

cites work

Murine Model for Dengue Virus-Induced Lethal Disease with Increased Vascular Permeability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

Dengue Fever in Humanized NOD/SCID Mice

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

Dengue: defining protective versus pathologic immunity

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

Dengue: an escalating problem

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

New mouse model for dengue virus vaccine testing

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

Study of Dengue virus infection in SCID mice engrafted with human K562 cells.

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

Pharmacological actions of PCA 4248, a new platelet-activating factor receptor antagonist: in vivo studies

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

Characterization of a dengue patient cohort in Recife, Brazil.

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

Wild dengue virus types 1, 2 and 3 viremia in rhesus monkeys

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

Natural history of dengue virus (DENV)-1 and DENV-4 infections: reanalysis of classic studies.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

A cascade of cytokines mediates mechanical inflammatory hypernociception in mice.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

Rodent models for the study of therapy against flavivirus infections

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

Development of a novel mouse model for dengue virus infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

Early clinical and laboratory indicators of acute dengue illness

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

A higher production of platelet activating factor in ex vivo heterologously secondary dengue-2 virus infections

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

UK-74,505, a novel and selective PAF antagonist, exhibits potent and long lasting activity in vivo

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor

2 June 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0906467106

Dengue: defining protective versus pathologic immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0906467106

Experimental Trypanosoma cruzi infection in platelet-activating factor receptor-deficient mice

21 January 2018

3 references

https://api.crossref.org/works/10.1073%2FPNAS.0906467106

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729033

27 November 2018

12 December 2020

Platelet activating factor receptor-deficient mice present delayed interferon-γ upregulation and high susceptibility to Leishmania amazonensis infection

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0906467106

A lethal role of platelet activating factor in anaphylactic shock in mice

21 January 2018

1 reference

12 December 2020

Effect of a novel potent platelet-activating factor antagonist, modipafant, in clinical asthma

1 reference

12 December 2020

Signaling via platelet-activating factor receptors accounts for the impairment of neutrophil migration in polymicrobial sepsis

1 reference

12 December 2020

Decreased organ failure in patients with severe SIRS and septic shock treated with the platelet-activating factor antagonist TCV-309: a prospective, multicenter, double-blind, randomized phase II trial. TCV-309 Septic Shock Study Group

1 reference

12 December 2020